Merck Warns That Slowdown in Medical Care Will Hurt Its Sales

Bookmark
(Bloomberg) -- Merck & Co. shares declined on fears that the drugmaker’s sales will suffer as more routine medical care is put off in the face of the coronavirus pandemic.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.